Management of Iatrogenic Tremor
Iatrogenic tremor should be managed by first identifying and discontinuing or reducing the offending medication when possible, followed by symptomatic treatment with propranolol (80-240 mg/day) or primidone as first-line agents if tremor persists and significantly impacts function. 1
Identify and Address the Causative Agent
The cornerstone of managing iatrogenic tremor is identifying the medication or intervention causing the tremor. Common culprits include:
- Stimulants and sympathomimetics that increase catecholamine release 2
- Valproate, lithium, corticosteroids, and certain antidepressants 3
- Caffeine and other substances that can enhance physiologic tremor 4, 2
When medically feasible, discontinue or reduce the dose of the offending agent. This is the most direct approach and may resolve the tremor entirely without need for additional treatment. 2
Pharmacological Management When Tremor Persists
If the causative medication cannot be discontinued or if tremor persists despite dose reduction:
First-Line Treatment
Propranolol (80-240 mg/day) is the most established first-line treatment, having been used for over 40 years with demonstrated efficacy in up to 70% of patients. 1, 4 This beta-blocker is particularly effective for postural and action tremors. 4
Primidone is an equally effective first-line alternative, though clinical benefits may not become apparent for 2-3 months, so an adequate trial period is essential. 1 Therapeutic benefit can occur even when derived phenobarbital levels remain subtherapeutic, confirming primidone itself has anti-tremor properties. 1
Important Contraindications and Precautions
Avoid beta-blockers in patients with:
Common adverse effects of beta-blockers include fatigue, depression, dizziness, hypotension, exercise intolerance, sleep disorders, cold extremities, and bronchospasm. 1 In elderly patients, excessive heart rate reduction may lead to serious adverse events. 1, 4
For primidone, counsel women of childbearing age about teratogenic risks (neural tube defects), and monitor for behavioral disturbances, irritability, and sleep disturbances, particularly at higher doses. 1
Second-Line Options
If first-line agents fail or are contraindicated:
- Nadolol (40-320 mg daily) - alternative beta-blocker with evidence for tremor control 1, 4
- Metoprolol (25-100 mg extended release daily or twice daily) 1, 4
- Gabapentin - has limited evidence for moderate efficacy 1, 4
Non-Pharmacological Approaches
Lifestyle modifications are particularly important for enhanced physiologic tremor:
- Avoid strenuous exercise before precision tasks 4, 2
- Reduce caffeine consumption 4, 2
- Implement stress reduction techniques 4, 2
Rhythm modification techniques can provide additional benefit:
- Superimpose alternative voluntary rhythms on top of the existing tremor and gradually slow all movement to complete rest 5, 4
- For unilateral tremor, use the unaffected limb to dictate a new rhythm (tapping/opening and closing the hand) to entrain the tremor to stillness 5, 4
- Use gross rather than fine movements for activities like handwriting (marker on large paper rather than normal handwriting) 5, 4
- Assist the person to relax muscles in the limb to prevent cocontraction 5
Critical Pitfall to Avoid
Do not prescribe aids and equipment in the acute phase, as they may interrupt normal automatic movement patterns and cause maladaptive functioning. 5 If aids are necessary for safety (e.g., safe hospital discharge), they should be considered short-term solutions with a minimalist approach and a clear plan to progress toward independence. 5
Surgical Options for Refractory Cases
Surgical therapies should be considered when medications fail due to lack of efficacy at maximum doses, dose-limiting side effects, or medical contraindications. 1
Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy shows sustained tremor improvement of 56% at 4 years with the lowest complication rate (4.4%) compared to radiofrequency thalamotomy (11.8%) and deep brain stimulation (21.1%). 1, 4 However, MRgFUS is contraindicated bilaterally, in patients unable to undergo MRI, or those with skull density ratio <0.40. 1, 4
Deep brain stimulation (DBS) is preferred for bilateral tremor or when MRgFUS is contraindicated, offering adjustable and reversible tremor control. 1
Treatment Algorithm
- Identify and discontinue/reduce the offending medication when medically feasible 2
- If tremor persists and impacts function, initiate propranolol (80-240 mg/day) or primidone 1, 4
- If first-line agents fail or are contraindicated, trial second-line medications (nadolol, metoprolol, or gabapentin) 1, 4
- For severe, medication-refractory tremor, consider surgical options: MRgFUS for unilateral tremor or DBS for bilateral involvement 1, 4